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INTRODUCTION
Depression is common. The point prevalence for major depressive disorder is 2.3-3.2% among men and 4.5-9.3% among women. ( depression improves overall quality of life and can be cost-effective. (6) In this article, "depression" connotes major depression, defined by the Diagnostic and Statistical
Manual IV (DSM-IV) as a period of at least two weeks during which a patient feels sad most of the day (or has loss of interest in pleasurable activities) and at least four other symptoms. (7) Most practice guidelines only address treatment of major depression. Dysthymia (or chronic depression) has not been studied as extensively, although some studies show that treatment for dysthymia is efficacious, and some guidelines apply treatments for major depression to dysthymia.(3) Depressive symptoms that do not meet full criteria for major depression or dysthymia are commonly referred to as subthreshold depression (classified under Depressive Disorders, Not Otherwise Specified or Minor Depressive Disorder in DSM-IV), a disorder for which little conclusive evidence of efficacious treatment exists. The indicators described in this paper are specific to major depression or dysthymia. Because many primary care
clinicians do not differentiate between subtypes of depression, the indicators are aimed to apply if a "depression" diagnosis is noted. If the clinician specifically diagnoses minor or subthreshold depression, then the indicators do not apply.
METHODS
The methods for developing these quality indicators, including literature review and expert panel deliberation, are detailed in a preceding paper.(8) For depression, the structured literature review 3 identified 3317 titles, from which abstracts and articles were identified that were relevant. Based on the literature and the authors' expertise, 32 potential quality indicators were proposed. Because most depression research has not focused on older adults, these quality of care indicators are largely based on research conducted on non-elderly patients.
RESULTS
Of the 32 proposed quality indicators, 17 were judged valid by the expert panel process (see Quality Indicator table) , two were merged with other indicators, and 13 were not accepted.
The literature summaries supporting each of the indicators accepted as valid are described below.
Quality Indicator #1
Recognizing Depression IF a vulnerable elder presents with new onset of one the following symptoms: sad mood, feeling down; insomnia or difficulties with sleep; apathy or loss of interest in pleasurable activities; complaints of memory loss; unexplained weight loss of greater than 5% in the past month or 10% over one year; or unexplained fatigue or low energy, THEN the patient should be asked about or treated for depression, or referred to a mental health professional within two weeks of presentation BECAUSE investigation of symptoms will lead to timely recognition and treatment of depression. within two months (1)), myocardial infarction (18-25% (1)), dementia (30-40% (1)), and malignancy (24% (1)).
Patients with chronic pain are much more likely to have depression. The AHCPR,(1) American Medical Directors Association (AMDA), (23) and APA (19) recommend documenting DSM symptoms of depression. This step is essential, since the evidence for the treatment efficacy for major depression and dysthymia is strong, but treatment is relatively unstudied for non-major forms of depression. (1) In one prospective cohort study, primary care physicians were asked to refer "depressed" patients for antidepressant therapy. Evaluation using DSM criteria revealed that some patients had major depression while others had minor depression. Only the patients with major depression improved with medication. (18) This finding suggests that primary care physicians need to be able to distinguish the symptoms of major from minor depression in order to identify patients who will benefit from treatment. Because it is impractical for clinicians to document all nine DSM-IV signs/symptoms, and because a smaller number would suffice to monitor therapeutic response, the indicator requires that physicians document three of nine symptoms.
The AHCPR guidelines suggest that full responders should be maintained on the same dose of medication found effective in acute phase treatment for 4 to 9 months of continuation treatment. ABFP guidelines dictate that responders should receive 9-12 months of treatment following recovery. (24) According to AHCPR, patients who responded to depression treatment should be followed-up by a clinician at least every 1 to 3 months during the continuation phase to evaluate symptoms, efficacy and side effects, and to promote adherence. (5) In contrast, a study of 17 primary care depression treatment revealed a mean total of only two to three follow-up visits, leading to conjecture that lack of appropriate follow-up contributed to the worse-than-expected outcomes for depression treatment in primary care.(18)
DISCUSSION
Depression is associated with significant morbidity and mortality in vulnerable elders.
Improvement in the quality of care that these patients receive may result in improved outcomes.
We describe 17 process measures believed to be valid indicators for use in quality of care measurement. These indicators can potentially serve as a basis to compare the care provided by various health care delivery systems and the changes in care over time.
